Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
42nd Annual Meeting of the American Society of Clinical Oncology
Progress in the Search for Improved Prognosis in Malignant Glioma
Atlanta, Georgia / June 2-6, 2006
Atlanta - Brain tumours account for only 1.5% of all cancers but cause substantial morbidity and mortality. The American Cancer Society estimates that approximately 19,000 malignant brain tumours are diagnosed in the US each year, and...
42nd Annual Meeting of the American Society of Clinical Oncology
Update on New Strategies for the Treatment of Gastrointestinal Cancers
Atlanta, Georgia / June 2-5, 2006
Atlanta - When added to standard chemotherapy regimens for metastatic colorectal cancer, bevacizumab, a monoclonal antibody against vascular endothelial growth factor, demonstrated improved progression-free and overall patient survival. The...
42nd Annual Meeting of the American Society of Clinical Oncology
Update on Targeted Therapies for Non-small Cell Lung Cancer
Atlanta, Georgia / June 2-6, 2006
Atlanta - The first real improvement in the treatment of advanced non-small cell lung cancer (NSCLC) to emerge in decades has been the development of targeted therapies. One of these is erlotinib, an orally active, potent and selective...
42nd Annual Meeting of the American Society of Clinical Oncology
Refining Targeted Strategies for the Treatment of Chronic and Acute Myeloid Leukemia
Atlanta, Georgia / June 2-6, 2006
Atlanta - Current Canadian recommendations indicate that imatinib should be initiated as first-line therapy for patients in chronic-phase chronic myeloid leukemia (CML). Despite the tyrosine kinase inhibitor’s (TKI’s) excellent activity in...
42nd Annual Meeting of the American Society of Clinical Oncology
Lymphoma Update: Reviewing Maintenance and Induction-phase Therapy
Atlanta, Georgia / June 2-6, 2006
Atlanta - Outcomes for patients with follicular lymphoma had changed very little over four decades of treatment until the emergence of chemoimmunotherapy. Studies presented here this year confirmed earlier findings that the anti-CD20...
42nd Annual Meeting of the American Society of Clinical Oncology
Chemopreventive Strategies in Prostate Cancer: Resolving an Enigma
Atlanta, Georgia / June 2-5, 2006
Atlanta - The Prostate Cancer Prevention Trial showed that treatment with the 5-alpha reductase inhibitor finasteride reduced the period prevalence of prostate cancer by 25% over its seven-year span compared with placebo. However, questions...
42nd Annual Meeting of the American Society of Clinical Oncology
Metastatic Breast Cancer
Atlanta, Georgia / June 2-6, 2006
Atlanta - Breast cancer is the most frequently diagnosed cancer in Canadian women, accounting for about 30% of all new cancer cases each year. Fortunately it is one of the most responsive of all treatable malignancies, and patients...
101st Annual Meeting of the American Urological Association (AUA)
Novel Findings and Therapy Strategies in Prostate Disease
Atlanta, Georgia / May 20-25, 2006
Atlanta - With the aging of western populations, the spectre of prostate disease emerges as a major health issue, with an estimated 12 million men in the US who have enlarged prostates and another 1.6 million who have prostate cancer. The...
101st Annual Meeting of the American Urological Association
The Evolution of 5-alpha Reductase Inhibition in Benign Prostatic Hyperplasia and Prostate Cancer Prevention
Atlanta, Georgia / May 20-25, 2006
Atlanta - Prostate disease poses a major health issue whose scope and consequences will continue to grow as Western populations age. According to the National Cancer Institute of Canada, in 2006, almost 21,000 Canadian men will be diagnosed...